230 related articles for article (PubMed ID: 3500727)
21. Immunogenetics of polymyalgia rheumatica.
al-Jarallah KF; Buchanan WW; Sastry A; Singal DP
Clin Exp Rheumatol; 1993; 11(5):529-31. PubMed ID: 8275589
[TBL] [Abstract][Full Text] [Related]
22. Increased frequency of HLA-DR3 and DR4 in polymyalgia rheumatica-giant cell arteritis.
Lowenstein MB; Bridgeford PH; Vasey FB; Germain BF; Espinoza LR
Arthritis Rheum; 1983 Jul; 26(7):925-7. PubMed ID: 6603224
[No Abstract] [Full Text] [Related]
23. Giant cell arteritis and polymyalgia rheumatica: two different but often overlapping conditions.
Gonzalez-Gay MA
Semin Arthritis Rheum; 2004 Apr; 33(5):289-93. PubMed ID: 15079759
[TBL] [Abstract][Full Text] [Related]
24. Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica.
González-Gay MA; García-Porrúa C; Vázquez-Caruncho M
J Rheumatol; 1998 Sep; 25(9):1750-5. PubMed ID: 9733456
[TBL] [Abstract][Full Text] [Related]
25. [Distribution of HLA-DR antigens in unrelated giant cell arteritis].
Ninet J; Gebuhrer L; Bonvoisin B; Mackiewicz R; Laurent H; Boussuge C; Rousset H; Le Petit JC; Betuel H
Presse Med; 1987 Oct; 16(35):1725-8. PubMed ID: 2962084
[TBL] [Abstract][Full Text] [Related]
26. HLA antigens in polymyalgia rheumatica in northern Sweden.
Uddhammar A; Sojka BN; Rantapää-Dahlqvist S
Clin Rheumatol; 1996 Sep; 15(5):486-90. PubMed ID: 8894363
[TBL] [Abstract][Full Text] [Related]
27. Anticardiolipin antibodies in polymyalgia rheumatica-giant cell arteritis: association with severe vascular complications.
Espinoza LR; Jara LJ; Silveira LH; Martínez-Osuna P; Zwolinska JB; Kneer C; Aguilar JL
Am J Med; 1991 Apr; 90(4):474-8. PubMed ID: 2012088
[TBL] [Abstract][Full Text] [Related]
28. [Giant cell arteritis--a genetically-determined disease?].
Schwizer B; Pirovino M
Schweiz Med Wochenschr; 1994 Nov; 124(44):1959-61. PubMed ID: 7973527
[TBL] [Abstract][Full Text] [Related]
29. Anti-neutrophil cytoplasm antibodies in patients with giant cell arteritis and/or polymyalgia rheumatica.
Berthelot JM; Lamour A; Mottier D; Pennec YL; Dueymes M; Jouquan J; Le Goff P; Youinou P
Ann Med Interne (Paris); 1992; 143(7):429-32. PubMed ID: 1300861
[TBL] [Abstract][Full Text] [Related]
30. IL-6 promoter polymorphism at position -174 modulates the phenotypic expression of polymyalgia rheumatica in biopsy-proven giant cell arteritis.
Gonzalez-Gay MA; Hajeer AH; Dababneh A; Garcia-Porrua C; Mattey DL; Amoli MM; Thomson W; Ollier WE
Clin Exp Rheumatol; 2002; 20(2):179-84. PubMed ID: 12051396
[TBL] [Abstract][Full Text] [Related]
31. Homocysteine levels in polymyalgia rheumatica and giant cell arteritis: influence of corticosteroid therapy.
Martinez-Taboada VM; Bartolome MJ; Fernandez-Gonzalez MD; Blanco R; Rodriguez-Valverde V; Lopez-Hoyos M
Rheumatology (Oxford); 2003 Sep; 42(9):1055-61. PubMed ID: 12730520
[TBL] [Abstract][Full Text] [Related]
32. Are polymyalgia rheumatica and giant cell arteritis the same disease?
Cantini F; Niccoli L; Storri L; Nannini C; Olivieri I; Padula A; Boiardi L; Salvarani C
Semin Arthritis Rheum; 2004 Apr; 33(5):294-301. PubMed ID: 15079760
[TBL] [Abstract][Full Text] [Related]
33. Risk of malignancy in patients with giant cell arteritis and polymyalgia rheumatica: a systematic review and meta-analysis.
Ungprasert P; Sanguankeo A; Upala S; Knight EL
Semin Arthritis Rheum; 2014 Dec; 44(3):366-70. PubMed ID: 25074657
[TBL] [Abstract][Full Text] [Related]
34. Association of the CXCL9-CXCR3 and CXCL13-CXCR5 axes with B-cell trafficking in giant cell arteritis and polymyalgia rheumatica.
Graver JC; Abdulahad W; van der Geest KSM; Heeringa P; Boots AMH; Brouwer E; Sandovici M
J Autoimmun; 2021 Sep; 123():102684. PubMed ID: 34237649
[TBL] [Abstract][Full Text] [Related]
35. Disturbed B cell homeostasis in newly diagnosed giant cell arteritis and polymyalgia rheumatica.
van der Geest KS; Abdulahad WH; Chalan P; Rutgers A; Horst G; Huitema MG; Roffel MP; Roozendaal C; Kluin PM; Bos NA; Boots AM; Brouwer E
Arthritis Rheumatol; 2014 Jul; 66(7):1927-38. PubMed ID: 24623536
[TBL] [Abstract][Full Text] [Related]
36. Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica.
González-Gay MA; Amoli MM; Garcia-Porrua C; Ollier WE
Semin Arthritis Rheum; 2003 Aug; 33(1):38-48. PubMed ID: 12920695
[TBL] [Abstract][Full Text] [Related]
37. Epitope mapping of antibodies against ferritin heavy chain in giant cell arteritis and polymyalgia rheumatica.
Große K; Schmidt RE; Witte T; Baerlecken NT
Scand J Rheumatol; 2013; 42(3):215-9. PubMed ID: 23682607
[TBL] [Abstract][Full Text] [Related]
38. Th1 and Th17 lymphocytes expressing CD161 are implicated in giant cell arteritis and polymyalgia rheumatica pathogenesis.
Samson M; Audia S; Fraszczak J; Trad M; Ornetti P; Lakomy D; Ciudad M; Leguy V; Berthier S; Vinit J; Manckoundia P; Maillefert JF; Besancenot JF; Aho-Glele S; Olsson NO; Lorcerie B; Guillevin L; Mouthon L; Saas P; Bateman A; Martin L; Janikashvili N; Larmonier N; Bonnotte B
Arthritis Rheum; 2012 Nov; 64(11):3788-98. PubMed ID: 22833233
[TBL] [Abstract][Full Text] [Related]
39. The spectrum of polymyalgia rheumatica in northwestern Spain: incidence and analysis of variables associated with relapse in a 10 year study.
González-Gay MA; García-Porrúa C; Vázquez-Caruncho M; Dababneh A; Hajeer A; Ollier WE
J Rheumatol; 1999 Jun; 26(6):1326-32. PubMed ID: 10381051
[TBL] [Abstract][Full Text] [Related]
40. Immunoglobulin (Gm) allotype frequencies in patients with giant bell arteritis and polymyalgia rheumatica.
Demaine AG; Vaughan RW; Behn AR; Myles AB; Panayi GS; Welsh KI
J Immunogenet; 1983 Oct; 10(5):343-8. PubMed ID: 6644068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
